Dialyzer reuse - Part II: Advantages and disadvantages

Seminars in Dialysis

Volumn 19, Issue 3, 2006, Pages 217-226

  Twardowski, Zbylut J ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; CELLOPHANE; CELLULOSE; CUPROPHANE; DISINFECTANT AGENT; DRUG DERIVATIVE; ETHYLENE OXIDE; HEMODIALYSIS FLUID;

ANAPHYLAXIS; ARTIFICIAL MEMBRANE; CHEMICALLY INDUCED DISORDER; COMPLEMENT ACTIVATION; DISINFECTION; DRUG EFFECT; EQUIPMENT; HUMAN; NEUTROPENIA; RECYCLING; REVIEW;

ANAPHYLAXIS; BIOCOMPATIBLE MATERIALS; CELLOPHANE; CELLULOSE; COMPLEMENT ACTIVATION; DISINFECTANTS; DISINFECTION; EQUIPMENT CONTAMINATION; EQUIPMENT REUSE; ETHYLENE OXIDE; HEMODIALYSIS SOLUTIONS; HUMANS; MEMBRANES, ARTIFICIAL; NEUTROPENIA;

EID: 33646675811     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2006.00158.x     Document Type: Review

References (86)

1. Twardowski ZJ: Dialyzer reuse - part I: historical perspective. Semin Dial 19: 41 53, 2006
2. Ogden DA: New-dialyzer syndrome. N Engl J Med 302: 1962 1963, 1980
3. Popli S, Ing TS, Daugirdas JT, Kheirbek AO, Viol GW, Vilbar RM, Gandhi VC: Severe reactions to Cuprophan capillary dialyzers. Artif Organs 6: 312 315, 1982
4. Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V: Dialyser reprocessing with Renalin®. Am J Nephrol 11: 27 31, 1991
5. Kaplow LS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1135 1137, 1968
6. Gral T, Schroth P, De Palma JR, Gordon A: Leukocyte dynamics with three types of hemodialyzers. Trans Am Soc Artif Intern Organs 15: 45 49, 1969
7. Toren M, Goffinet JA, Kaplow LS: Pulmonary bed sequestration of neutrophils during hemodialysis. Blood 36: 337 340, 1970
8. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769 774, 1977
9. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacob HS: Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879 888, 1977
10. Hakim RM, Lowrie EG: Effect of dialyzer reuse on leukopenia, hypoxemia and total hemolytic complement system. Trans Am Soc Artif Intern Organs 26: 159 164, 1980
11. Hakim RM, Lowrie EG: Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials. Nephron 32: 32 39, 1982
12. Gutch CF, Eskelson CD, Ziegler E, Odgen DA: 2-Chloroethanol as a toxic residue in dialysis supplies sterilized with ethylene oxide. Dial Transplant 5: 21 25, 1976
13. Poothullil J, Shimizu A, Day RP, Dolovich J: Anaphylaxis from the product(s) of ethylene oxide gas. Ann Intern Med 82: 58 60, 1975
14. Grammer LC, Paterson BF, Roxe D, Daugirdas JT, Ing TS, Ivanovich PT, Brown CB, Nicholls AJ, Patterson R: IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol 76: 511 514, 1985
15. Oba T, Tsuji K, Nakamura A, Shintani H, Mizumachi S, Kikuchi H, Kaniwa M, Kojima S, Kanohta K, Kawasaki Y, Furuya T, Matsumoto K, Tobe M: Migration of acetylated hemicellulose from capillary hemodialyzer to blood, causing scleritis and/or iritis. Artif Organs 8: 429 435, 1984
16. Hutter JC, Kuehnert MJ, Wallis RR, Lucas AD, Sen S, Jarvis WR: Acute onset of decreased vision and hearing traced to hemodialysis treatment with aged dialyzers. JAMA 283: 2128 2134, 2000
17. Moore MA, Kaplan DS, Picciolo GL, Wallis RR, Kowolik MJ: Effect of cellulose acetate materials on the oxidative burst of human neutrophils. J Biomed Mater Res 55: 257 265, 2001
18. Averbukh Z, Modai D, Sandbank J, Berman S, Cohn M, Galperin E, Cohen N, Dishi V, Weissgarten J: Red eye syndrome: clinical and experimental experience in a new aspect of diffuse eosinophilic infiltration? Artif Organs 25: 437 440, 2001
19. Canaud B, European Experts Panel: Performance liquid test as a cause for sudden deaths of dialysis patients: perfluorohydrocarbon, a previously unrecognized hazard for dialysis patients. Nephrol Dial Transplant 17: 545 548, 2002
20. Shaldon S, Koch KM: Dialyzer repair: a disastrous exercise in cost effectiveness. ASAIO J 48: 453 454, 2002
21. Shaldon S: 22 years' experience with reuse. Dial Transplant 11: 569 570, 1982
22. Nässberger L, Arbin A, Östelius J: Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. Nephron 45: 286 290, 1987
23. Ganning AE, Brunk U, Dallner G: Phthalate esters and their effect on the liver. Hepatology 4: 541 547, 1984
24. Shea KM, American Academy of Pediatrics Committee on Environmental Health: Pediatric exposure and potential toxicity of phthalate plasticizers. Pediatrics 111 6 pt 1 1467 1474, 2003
25. Schoenfeld PY: The technology of dialyzer reuse. Semin Nephrol 17: 321 330, 1997
26. Fischbach LJ: Renalin: qualification as a dialyzer sterilant. In: AAMI Standards and Recommended Practices. Vol. 3, Dialysis. Arlington, VA: Association for the Advancement of Medical Instrumentation, 1993: 195 199
27. Kramps JA, Peltenburg LTC, Kerklaan PR, Spieksma FT, Valentijn RM, Dijkman JH: Measurement of specific IgE antibodies in individuals exposed to formaldehyde. Clin Exp Allergy 19: 509 514, 1989
28. Di Stefano F, Siriruttanapruk S, McCoach JS, Burge PS: Occupational asthma due to glutaraldehyde. Monaldi Arch Chest Dis 53: 50 55, 1998
29. Miller GB Jr., Sikes RK, US Centers for Disease Control: Acute allergic reactions associated with reprocessed dialyzers - Virginia, 1989. MMWR 38: 873 874, 1989
30. Miller GB, Wilber J, US Centers for Disease Control: Update: acute allergic reactions associated with reprocessed dialyzers - United States, 1989-1990. MMWR 40: 147 153, 1991
31. Pegues DA, Beck-Sague CM, Woollen SW, Greenspan B, Burns SM, Bland LA, Arduino MJ, Favero MS, Mackow RC, Jarvis WR: Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 42: 1232 1237, 1992
32. Lewis KJ, Ward MK, Kerr DNS: Residual formaldehyde in dialyzers: quantity, location, and the effect of different methods of rinsing. Artif Organs 5: 269 277, 1981
33. Stragier A, Wenderickx D, Jadoul M: Rinsing time and disinfectant release of reused dialyzers: comparison of formaldehyde, hypochlorite, Warexin, and Renalin. Am J Kidney Dis 26: 549 553, 1995
34. Tanaka N, Tanaka N, Fujisawa T, Daimon T, Fujiwara K, Yamamoto M, Abe T: The use of electrolyzed solutions for the cleaning and disinfecting of dialyzers. Artif Organs 24: 921 928, 2000
35. Pollard TL, Barnett BMS, Eschbach JW, Scribner BH: A technique for storage and multiple re-use of the Kiil dialyzer and blood tubing. Trans ASAIO 13: 24 28, 1967
36. Carson LA, Petersen NJ, Favero MS, Aguero SM: Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 36: 839 846, 1978
37. Carson LA, Bland LA, Cusick LB, Favero MS, Bolan GA, Reingold AL, Good RC: Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 54: 3122 3125, 1988
38. Hakim RM, Friedrich RA, Lowrie EG: Formaldehyde kinetics and bacteriology in dialyzers. Kidney Int 28: 936 943, 1985
39. Bolan G, Reingold AL, Carson LA, Silcox VA, Woodley CL, Hayes PS, Hightower AW, McFarland L, Brown JW III., Petersen NJ, Favero MS, Good RC: Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis 152: 1013 1019, 1985
40. Lowry PW, Beck-Sague CM, Bland LA, Aguero SM, Arduino MJ, Minuth AN, Murray RA, Swenson JM, Jarvis WR: Mycobacterium chelonae infection among patients receiving high-flux dialysis in a hemodialysis clinic in California. J Infect Dis 161: 85 90, 1990
41. Gordon SM, Tipple M, Bland LA, Jarvis WR: Pyrogenic reactions associated with the reuse of disposable hollow-fiber hemodialyzers. JAMA 260: 2077 2081, 1988
42. Gordon SM, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Favero MS, Jarvis WR: Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. J Am Soc Nephrol 2: 1436 1444, 1992
43. Ronco C: Backfiltration: a controversial issue in modern dialysis. Int J Artif Organs 11: 69 74, 1988
44. Urena P, Herbelin A, Zingraff J, Lair M, Man NK, Descamps-Latscha B, Drueke T: Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Nephrol Dial Transplant 7: 16 28, 1992
45. Alter MJ, Favero MS, Miller JK, Coleman PJ, Bland LA: Reuse of hemodialyzers. Results of nationwide surveillance for adverse effects. JAMA 260: 2073 2076, 1988
46. Alter MJ, Favero MS, Moyer LA, Miller JK, Bland LA: National surveillance of dialysis-associated diseases in the United States, 1988. Trans Am Soc Artif Intern Organs 36: 107 118, 1990
47. Pegues DA, Oettinger CW, Bland LA, Oliver JC, Arduino MJ, Aguero SM, McAllister SK, Gordon SM, Favero MS, Jarvis WR: A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. J Am Soc Nephrol 3: 1002 1007, 1992
48. Twardowski Z, Lebek R, Nowak H, Gajdzik C: Wielokrotne užycie dializatora. Prosty i bezpieczny sposób zmniejszenia kosztów dializy [Repeated use of dialyzer. A simple and safe method for lowering the cost of dialysis]. Pol Arch Med Wewn 48: 171 176, 1972
49. Lazarus JM, Friedrich RA, Merrill JP: Hollow fiber kidney reuse. Dial Transplant 2: 14 16, 32, 1973
50. Gotch FA: Mass transport in reused dialyzers. Proc Clin Dial Transplant Forum 10: 81 85, 1980
51. Gagnon RF, Kaye M: Dialyzer performance over prolonged reuse. Clin Nephrol 24: 21 27, 1985
52. National Kidney Foundation: Revised standards for reuse of hemodialyzers. Am J Kidney Dis 3: 466 468, 1984
53. Delmez JA, Weerts CA, Hasamear PD, Windus DW: Severe dialyzer dysfunction undetectable by standard reprocessing validation tests. Kidney Int 36: 478 484, 1989
54. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation. Am J Kidney Dis 30: 859 871, 1997
55. Garred LJ, Canaud B, Flavier JL, Poux C, Polito-Bouloux C, Mion C: Effect of reuse on dialyzer efficacy. Artif Organs 14: 80 84, 1990
56. Ouseph R, Smith BP, Ward RA: Maintaining blood compartment volume in dialyzers reprocessed with peracetic acid maintains Kt/V but not beta2-microglobulin removal. Am J Kidney Dis 30: 501 506, 1997
57. Cheung AK, Agodoa LY, Daugirdas JT, Depner TA, Gotch FA, Greene T, Levin NW, Leypoldt JK: Effects of hemodialyzer reuse on clearances of urea and β2-microglobulin. The Hemodialysis (HEMO) Study Group. J Am Soc Nephrol 10: 117 127, 1999
58. Sherman RA, Cody RP, Rogers ME, Solanchick JC: The effect of dialyzer reuse on dialysis delivery. Am J Kidney Dis 24: 924 926, 1994
59. Murthy BVR, Sundaram S, Jaber BL, Perrella C, Meyer KB, Pereira BJG: Effect of formaldehyde/bleach reprocessing on in vivo performances of high-efficiency cellulose and high-flux polysulfone dialyzers. J Am Soc Nephrol 9: 464 472, 1998
60. Röckel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D: Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int 30: 429 432, 1986
61. Leypoldt JK, Cheung AK, Deeter RB: Effect of hemodialyzer reuse: dissociation between clearances of small and large solutes. Am J Kidney Dis 32: 295 301, 1998
62. Diaz RJ, Washburn S, Cauble L, Siskind MS, Van Wyck D: The effect of dialyzer reprocessing on performance and β2-microglobulin removal using polysulfone membranes. Am J Kidney Dis 21: 405 410, 1993
63. Kaplan AA, Halley SE, Lapkin RA, Graeber CW, Graeber CA: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47: 573 578, 1995
64. Krautzig S, Mahiout A, Koch KM, Lemke HD: Reuse with oxidizing agents leads to a loss of polyvinylpyrrolidone from polysulfone membrane [abstract]. Blood Purif 12: 176, 1994
65. Ward RA, Ouseph R: Impact of bleach cleaning on the performance of dialyzers with polysulfone membranes processed for reuse using peracetic acid. Artif Organs 27: 1029 1034, 2003
66. Held PJ, Wolfe RA, Gaylin DS, Port FK, Levin NW, Turenne MN: Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23: 692 708, 1994
67. Port FK, Wolfe RA, Hulbert-Shearon TE, Daugirdas JT, Agodoa LYC, Jones C, Orzol SM, Held PJ: Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 37: 276 286, 2001
68. Manns BJ, Taub K, Richardson RMA, Donaldson C: To reuse or not to reuse? An economic evaluation of hemodialyzer reuse versus conventional single-use hemodialysis for chronic hemodialysis patients. Int J Technol Assess Health Care 18 1 81 93, 2002
69. Feldman HI, Kinosian M, Bilker WB, Simmons C, Holmes JH, Pauly MV, Escarce JJ: Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 276: 620 625, 1996
70. Feldman HI, Bilker WB, Hackett M, Simmons CW, Holmes JH, Pauly MV, Escarce JJ: Association of dialyzer reuse and hospitalization rates among hemodialysis patients in the US. Am J Nephrol 19: 641 648, 1999
71. Okechukwu CN, Orzol SM, Held PJ, Pereira BJ, Agodoa LY, Wolfe RA, Port FK: Characteristics and treatment of patients not reusing dialyzers in reuse units. Am J Kidney Dis 36: 991 999, 2000
72. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Reprocessing dialyzers for multiple uses: recent analysis of death risks for patients. Nephrol Dial Transplant 19: 2823 2830, 2004
73. Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Measurement of dialyzer clearance, dialysis time, and body size: death risk relationships among patients. Kidney Int 66: 2077 2084, 2004
74. Williams AJ, McArley A: Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr 9 3 157 162, 1999
75. Valderrábano F: Weekly duration of dialysis treatment - does it matter for survival? Nephrol Dial Transplant 11: 569 572, 1996
76. Locatelli F, Manzoni C: Duration of dialysis session - was Hegel right? Nephrol Dial Transplant 14: 560 563, 1999
77. Lameire N: Management of the hemodialysis patient: a European perspective. Blood Purif 20: 93 102, 2002
78. Shaldon S: Adequacy of long-term hemodialysis. Curr Opin Nephrol Hypertens 1: 197 202, 1992
79. Doss H, Carlson W: Reuse: what does the industry think? Nephrol News Issues 18: 95, 97, 2004
80. Cornelius RM, McClung WG, Richardson RMA, Estridge C, Plaskos N, Yip CM, Brash JL: Effects of heat/citric acid reprocessing on high-flux polysulfone dialyzers. ASAIO J 48: 45 56, 2002
81. Tonelli M, Dymond C, Gourishankar S, Jindal KK: Extended reuse of polysulfone hemodialysis membranes using citric acid and heat. ASAIO J 50: 98 101, 2004
82. Kenley RS: Efficacy of heat disinfection with the Aksys personal hemodialysis system. Home Hemodial Int 1: 36 40, 1997
83. James J, Twardowski ZJ, Blagg CR, Bower JD, Kjellstrand CM: Effect of non-chemical hot water reuse on dialyzer performance [abstract]. J Am Soc Nephrol 12: 267A, 2001
84. Kjellstrand C, Twardowski ZJ, Bower J, Blagg CR: Hot water reuse (HWR) of dialysis filters gives smoother dialysis than single use (SU) or chemical reuse (CRU) [abstract]. J Am Soc Nephrol 14: 502A, 2003
85. Kjellstrand CM, Blagg CR, Bower J, Twardowski ZJ: The Aksys personal hemodialysis system. Semin Dial 17: 151 153, 2004
86. Kjellstrand CM, Blagg CR, Bower J, Young B, Twardowski ZJ: 106 Patient-years experience with the AKSYS PHD system for quotidian home hemodialysis [abstract]. Hemodial Int 9: 80 81, 2005